ARB treatment of high CV risk patients does not prevent renal failure - JAAPA

Links shared publicly online about this topic.

  • 1,761
    total visits

ARB treatment of high CV risk patients does not prevent renal failure - JAAPA

jaapa.com

Clinical question: In patients with heart disease or advanced diabetes, does the use of angiotensin-receptor blocker (ARB) treatment prevent the development of renal failure?

View full resource at jaapa.com

Tags: Heart, Heart Disease, Kidney Health, Urinary System, Kidney Disease, Kidney Failure

  • Share

Most Recently Shared on September 9, 2009 at 3:12 pm By:

JAAPAcom JAAPA

ARB treatment of high CV risk patients does not prevent renal failure: Clinical question: In patients with heart.. http://bit.ly/1UZbjH

3 years ago...

Advertisement